论文部分内容阅读
美国得克萨斯大学的一个研究小组,在研究甲氰咪胍对癌症患者的“免疫功能恢复调理”作用时,发现甲氰咪胍的一种新用途。1例服用甲氰咪胍的癌症患者左胸壁患有典型的带状疱疹,在免疫系统受到严重抑制的癌症患者中这是常见的现象。 患者服用甲氰咪胍300mg/d,共7d。用药第2d开始,带状疱疹的痛痒症状明显减轻,不久疱疹结痂而愈。患者的免疫系统功能在7d内恢复(根据局部移植物抗宿主反应)。 该研究小组继续对另外3例患有带状疱疹的癌症患者用甲氰咪胍进行短程治疗。这3例的症状在用药后48h内均得到缓解,而且疱疹均愈合。
A team of researchers at the University of Texas at Austin, Texas, has found a new use of cimetidine when studying the effect of cimetidine on “immune function regaining conditioning” in cancer patients. One patient with cancer who took cimetidine had a classic shingles on the left chest wall, a common phenomenon in cancer patients with a severely suppressed immune system. Patients taking cimetidine 300mg / d, a total of 7d. The first 2d medication, herpes zoster symptoms significantly reduced, and soon herpes scab and more. Patients’ immune system function recovered within 7 days (according to the local graft-versus-host reaction). The team continued with another three patients with shingles cancer patients with cimetidine for short-term treatment. The symptoms of these 3 cases were relieved within 48 hours after treatment, and herpes healed.